BIOMAT Database Logo BIOMAT Database Logo

Effects of neostigmine and pyridostigmine on duration of succinylcholine action and pseudocholinesterase activity. 1978

K Y Sunew, and R G Hicks

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D010830 Physostigmine A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. Eserine
D002091 Butyrylcholinesterase An aspect of cholinesterase (EC 3.1.1.8). Pseudocholinesterase,Benzoylcholinesterase,Butyrylthiocholinesterase
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Y Sunew, and R G Hicks
Duration of action of neostigmine and pyridostigmine in the elderly.
August 1988, Anesthesia and analgesia,
K Y Sunew, and R G Hicks
Ligated renal pedicles and duration of action of neostigmine and pyridostigmine.
August 1977, British journal of pharmacology,
K Y Sunew, and R G Hicks
Effects of neostigmine and pyridostigmine on serum cholinesterase activity.
January 1982, Canadian Anaesthetists' Society journal,
K Y Sunew, and R G Hicks
Effects of neostigmine and pyridostigmine on serum cholinesterase activity.
May 1982, Canadian Anaesthetists' Society journal,
K Y Sunew, and R G Hicks
Weight, pseudocholinesterase activity, and succinylcholine requirement.
July 1982, Anesthesiology,
K Y Sunew, and R G Hicks
Succinylcholine and pseudocholinesterase.
September 1973, JAMA,
K Y Sunew, and R G Hicks
Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity.
August 1981, British journal of anaesthesia,
K Y Sunew, and R G Hicks
Prolonged effect of succinylcholine after neostigmine and pyridostigmine administration in patients with renal failure.
April 1983, Anesthesiology,
K Y Sunew, and R G Hicks
[Succinylcholine and low serum pseudocholinesterase activity - effect of administration of purified human pseudocholinesterase].
October 1975, Masui. The Japanese journal of anesthesiology,
K Y Sunew, and R G Hicks
Letter: Succinylcholine and pseudocholinesterase.
January 1974, The New England journal of medicine,
Copied contents to your clipboard!